Results 81 to 90 of about 46,898 (102)
Slavonia - History of the Settlements and the Origins of Inhabitants, Mirko Marković
Kartografija i Geoinformacije, 2013 Ivka Kljajić
doaj
Role of Calcium Signaling in GA101-Induced Cell Death in Malignant Human B Cells [PDF]
Cancers, 2019 International audienceGA101/obinutuzumab is a novel type II anti-CD20 monoclonal antibody (mAb), which is more effective than rituximab (RTX) in preclinical and clinical studies when used in combination with chemotherapy.
Simon Latour +2 more
exaly +2 more sources
Molecular Cancer Therapeutics, 2011 International audienceGA101 is a novel glycoengineered Type II CD20 monoclonal antibody. When compared with rituximab, it mediates less complement-dependent cytotoxicity (CDC).
Lina Reslan +2 more
exaly +2 more sources
Unexpected cross-reactivity of anti-cathepsin B antibodies leads to uncertainties regarding the mechanism of action of anti-CD20 monoclonal antibody GA101 [PDF]
Leukemia Research, 2017 International audienceGA101, also known as obinutuzumab or Gazyva (Gazyvaro), is a glycoengineered type II humanized antibody that targets the CD20 antigen expressed at the surface of B-cells.
Jérôme Kucharczak +2 more
exaly +2 more sources
Journal of Clinical Oncology, 2013 International audiencePurposeObinutuzumab (GA101), a type II, glycoengineered, humanized anti-CD20 monoclonal antibody, was superior to rituximab in human diffuse large B-cell lymphoma (DLBCL) and mantle-cell lymphoma (MCL) xenograft models.
Guillaume Cartron +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches: